Skip to main content
Clinical Trials/NCT03787810
NCT03787810CompletedNot Applicable

Left Ventricular Dysfunction in Critically Ill Patients

Sahlgrenska University Hospital, Sweden1 site in 1 country428 target enrollmentStarted: May 28, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
428
Locations
1
Primary Endpoint
Mortality

Study Overview

Brief Summary

Left ventricular dysfunction is common in the critically ill. The aim of this study is to assess the incidence and prognosis of left ventricular dysfunction in critically ill patients.

Detailed Description

Left ventricular dysfunction is common in the critically ill. A number of conditions can cause left ventricular dysfunction including myocardial infarction, septic cardiomyopathy, post resuscitation syndrome, takotsubo syndrome etc. A number of studies have assessed cardiac dysfunction in specific conditions (e.g. sepsis, cardiac arrest) but only a few studies have assessed cardiac dysfunction in a general ICU-population. The study will focus on diagnostics of the different types of cardiomyopathy and differentiating between ischemic and non-ischemic left ventricular dysfunction in a general ICU population. The aim of this study is to assess the incidence and prognosis of the different types of left ventricular dysfunction in critically ill patients. Our hypothesis is that left ventricular dysfunction is common in the critically ill and is associated with an increased risk of short-term death.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Admitted within 24 hours to the ICU
  • Dysfunction of at least one organ system, defined as at least +1 point in SOFA-score.
  • Exclusion Criteria

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Mortality

Time Frame: 30 days

All cause mortality after admission to the ICU

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sahlgrenska University Hospital, Sweden
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jonatan Oras

Consultant, adjunct senior lecturer

Sahlgrenska University Hospital, Sweden

Study Sites (1)

Loading locations...

Similar Trials